Young Alethia (CIK 1918147) reported 11 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy PCRX (6,405 shares), Buy PTCT (4,000 shares), Buy BCYC (50,000 shares), Sell BCYC (3,289 shares), Sell BCYC (2,456 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Pacira BioSciences, Inc. (PCRX) | Director | Buy | 6,405 | $0 |
| 2026-01-06 | PTC THERAPEUTICS, INC. (PTCT) | Director | Buy | 4,000 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 3,289 | $22,365 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 2,456 | $15,841 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 1,878 | $12,282 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 217 | $1,823 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 265 | $2,282 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 204 | $1,446 |
| 2025-06-13 | Pacira BioSciences, Inc. (PCRX) | Director | Buy | 6,163 | $0 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 215 | $1,724 |
Source: SEC Form 4 filings · as of 2026-06-12